Contract awardedBrand strategy, identity and rebranding

Sub-brand architecture and strategy for the MHRA comes from M&C Saatchi

The Medicines and Healthcare products Regulatory Agency (MHRA) hired M&C Saatchi to review how its sub-brands fit together and set a strategy for them.

The MHRA wanted a focused piece of work that would give it a way forward on the sub-brands. It awarded the £60,000 contract directly, without a competition, in October 2026. The work is due to end in December 2026.

Alert me to similar tenders

Contract ends December 2026

What
Brand strategy, identity and rebranding
Supplier
M&C Saatchi
Value
£60,000
How it was bought
Below threshold - without competition
Dates and next
Oct 2026 to Dec 2026

How it was bought

1 official notice
  1. 6 Oct 2026Contract starts
  2. 8 Oct 2026Award noticeFind a Tender
  3. 1 Dec 2026Contract ends

How it compares

With every brand strategy, identity and rebranding award since 2021

Half of awards fall between £30,000 and £87,122Median £48,555

Awards
211
Firms that won them
185
Median award
£48,555
of 193 with a value
This award
Bigger than 63%
of them
Typical length
7 months
In London
43 awards

M&C Saatchi ranks 2nd of 185 firms for brand strategy, identity and rebranding awards since 2021.

RankFirmAwardsValue
1Locked5£1.68m
2M&C Saatchi Won this one4£3.81m
3Locked3£336,000
3Locked3£220,000
3Locked3£200,000
3Locked3£189,987
See who wins this work

Figures to 21 November 2026

Brand strategy, identity and rebranding at other buyers

Medicines and Healthcare products Regulatory Agency (MHRA) has awarded 421 contracts since 2021.

See Medicines and Healthcare products Regulatory Agency (MHRA)'s page
  • M&C Saatchi has won 35 public contracts since 2021.

3 brand strategy, identity and rebranding tenders are open now

See them
More brand strategy, identity and rebranding contracts awarded in 2026